Response to the Letter to the Editor “N-Acetylcysteine and Contrast-Induced Nephropathy”

Abstract

Get full access to this article

View all access options for this article.

References

Yayla

Gayretli Yayla

Unal

Acar

Akboga

Demirtas

. N-acetylcysteine and contrast-induced nephropathy. Angiology. 2018;69(1):85.

Sun

Zhu

, et al. Platelet to lymphocyte ratio predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2018;69(1):71–78.

Jurado-Roman

Hernandez-Hernandez

Garcia-Tejada

, et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol. 2015;115:1174–8.

Shalansky

Pate

Levin

Humphries

Webb

. N-acetylcysteine for prevention of radiographic contrast material induced nephropathy: is the intravenous route best? Pharmacotherapy. 2005;25:1095–103.

Tepel

van der Giet

Schwarzfeld

Laufer

Liermann

Zidek

. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180–4.

Rashid

Salman

Myint

, et al. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. J Vasc Surg. 2004;40:1136–41.

Webb

Pate

Humphries

, et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J. 2004;148:422–9.